Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Ovarian Neoplasms

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 14 articles: HTML format

Single Articles

January 2023
1. SCHROFELBAUER B, Kimes PK, Hauke P, Reid CE, et al
   Discovery of antibodies and cognate surface targets for ovarian cancer by surface profiling.
   Proc Natl Acad Sci U S A. 2023;120:e2206751120.
   PubMed     Abstract available
   
   
   October 2022
2. ZHAO G, Tan Y, Cardenas H, Vayngart D, et al
   Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.
   Proc Natl Acad Sci U S A. 2022;119:e2203480119.
   PubMed     Abstract available
   
   
   September 2022
3. PRAKASH R, Rawal Y, Sullivan MR, Grundy MK, et al
   Homologous recombination-deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants.
   Proc Natl Acad Sci U S A. 2022;119:e2202727119.
   PubMed     Abstract available
   
   
   August 2022
4. AKTORIES K
   Treatment of ovarian cancer with modified anthrax toxin.
   Proc Natl Acad Sci U S A. 2022;119:e2210179119.
   PubMed    
   
   
   July 2022
5. DURU N, Pawar NR, Martin EW, Buzza MS, et al
   Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.
   Proc Natl Acad Sci U S A. 2022;119:e2201423119.
   PubMed     Abstract available
   
   
   April 2022
6. OZMADENCI D, Shankara Narayanan JS, Andrew J, Ojalill M, et al
   Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.
   Proc Natl Acad Sci U S A. 2022;119:e2117065119.
   PubMed     Abstract available
   
   
   February 2022
7. PAFFENHOLZ SV, Salvagno C, Ho YJ, Limjoco M, et al
   Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer.
   Proc Natl Acad Sci U S A. 2022;119.
   PubMed     Abstract available
   
   
   November 2021
8. 
   Correction to Supporting Information for Choi et al., Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed    
   
   
   June 2021
9. GU S, Lheureux S, Sayad A, Cybulska P, et al
   Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   January 2021
10. XIAO Y, Lin FT, Lin WC
    ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    December 2020
11. IWAHASHI N, Ikezaki M, Nishikawa T, Namba N, et al
    Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.
    Proc Natl Acad Sci U S A. 2020;117:33225-33234.
    PubMed     Abstract available
    
    
    
12. KIM O, Park EY, Kwon SY, Shin S, et al
    Targeting progesterone signaling prevents metastatic ovarian cancer.
    Proc Natl Acad Sci U S A. 2020 Dec 1. pii: 2013595117.
    PubMed     Abstract available
    
    
    September 2020
13. SHON DJ, Malaker SA, Pedram K, Yang E, et al
    An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins.
    Proc Natl Acad Sci U S A. 2020;117:21299-21307.
    PubMed     Abstract available
    
    
    August 2020
14. HABER T, Cornejo YR, Aramburo S, Flores L, et al
    Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles.
    Proc Natl Acad Sci U S A. 2020;117:19737-19745.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.